Spruce Biosciences received FDA Breakthrough Therapy Designation for TA-ERT in treating San Filippo Syndrome Type B [MPS IIIB]. BTD enables potential rolling BLA submission, Priority Review, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback